Takeda Pharmaceutical (4502.T) Price/Sales Ratio
Market Cap: $7.18T
Avg Volume: 4.10M
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
What is Takeda Pharmaceutical's Price/Sales Ratio?
- Takeda Pharmaceutical's trailing twelve month (TTM) Price/Sales ratio is 1.57.
- Takeda Pharmaceutical's annual Price/Sales ratio as of today is 1.53.
- Takeda Pharmaceutical's quarterly Price/Sales ratio is 5.79.
What is the Price/Sales Ratio?
The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.
How is the Price/Sales Ratio calculated?
The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:
P/S Ratio = Market Capitalization / Total Sales (Revenue)
Related Metrics
Other important metrics to assess Takeda Pharmaceutical's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: 45.16
- Quarterly: 69.56
- TTM: 34.48
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 0.89
- Quarterly: 0.89
- TTM: 0.97
- P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: 9.08
- Quarterly: 17.25
- TTM: 6.68
- PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
- Annual: -0.82
- Quarterly: -0.94
- TTM: -1.21
These metrics provide insights into Takeda Pharmaceutical's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Price/Sales Ratio
1.53
Quarterly Price/Sales Ratio
5.79
TTM Price/Sales Ratio
1.57
Takeda Pharmaceutical Historical Price/Sales Ratio
Historical P/E Ratio
Historical P/B Ratio
Historical P/C Ratio
Historical PEG Ratio
Takeda Pharmaceutical Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Price/Sales Ratio | P/E Ratio | P/B Ratio | P/C Ratio | PEG Ratio |
|---|---|---|---|---|---|
| 2024 | 1.53 | 45.16 | 0.89 | 9.08 | -0.82 |
| 2023 | 1.68 | 21.29 | 1.06 | 6.91 | 0.55 |
| 2022 | 1.53 | 23.77 | 0.96 | 4.87 | -0.61 |
| 2021 | 1.95 | 16.55 | 1.20 | 6.16 | 0.02 |
| 2020 | 1.57 | 116.44 | 1.09 | 7.69 | -1.97 |
| 2019 | 3.42 | 65.76 | 1.39 | 21.85 | -0.93 |
| 2018 | 4.59 | 43.50 | 4.07 | 21.52 | 0.69 |
| 2017 | 4.74 | 71.36 | 4.33 | 31.38 | 1.63 |
| 2016 | 4.46 | 100.49 | 4.13 | 316.03 | -0.48 |
| 2015 | 5.29 | -64.55 | 4.40 | 51.55 | 0.38 |
Related Metrics
Explore detailed financial metrics and analysis for 4502.T.